Skip to main content

Advertisement

SpringerLink
Log in

Hepatic metastases from breast cancer

  • Original Article
  • Published:
Updates in Surgery Aims and scope Submit manuscript

Abstract

The prognosis of patients with hepatic metastasis from breast cancer treated with systemic or regional chemotherapy is disappointing. When technically feasible, liver resection offers the best results. Eighteen patients out of 22 submitted to laparotomy underwent radical liver resection. Median follow-up from liver resection was 36 months. The median time interval between breast cancer diagnosis and disease recurrence was 35 months. Median disease-free survival and overall survival from liver resection were 66 and 74 months, respectively. Median survival time from breast cancer surgery was 88.5 months. Surgical treatment of liver metastases should be carried out on young and older patients alike when site of metastases is the liver alone. Neoadjuvant treatment and preoperative diagnostic laparoscopy should be planned in future experience.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Wingo PA, Tong T, Bolden S (1995) Cancer statistics. CA Cancer J Clin 45(1):8–30

    Article  CAS  PubMed  Google Scholar 

  2. Valagussa P, Bonadonna G, Veronesi U (1978) Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer 41:1170–1178

    Article  CAS  PubMed  Google Scholar 

  3. Haagensen CD (1977) Treatment of curable carcinoma of the breast. J Radiol Oncol Biol Phys 2:975–980

    Article  CAS  Google Scholar 

  4. Wyld L, Gutteridge E, Pinder SE, James JJ, Chan SY, Cheung KL, Robertson JF, Evans AJ (2003) Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer 89:284–290

    Article  CAS  PubMed  Google Scholar 

  5. Perez JE, Machiavelli M, Leone BA, Romero A, Rabinovich MG, Vallejo CT, Bianco A, Rodriguez R, Quevas MA, Alvarez LA (1990) Bone-only versus visceral-only metastatic pattern in breast cancer: analysis of 150 patients. A GOCS study. Am J Clin Oncol 13:294–298

    Article  CAS  PubMed  Google Scholar 

  6. Baur M, Schlappack O, Havelec L, Wrba F, Dittrich C (2001) Prognostic significance of liver metastases as first site of generalisation in patients with breast cancer—a retrospective analysis. Acta Med Austriaca 28:135–140

    Article  CAS  PubMed  Google Scholar 

  7. Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G (2000) Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59:271–278

    Article  CAS  PubMed  Google Scholar 

  8. Insa A, Lluch A, Prosper F, Marugan I, Martinez-Agullo A, Garcia-Conde J (1999) Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat 56(1):67–78

    Article  CAS  PubMed  Google Scholar 

  9. Yoshimoto M, Tada T, Saito M, Takahashi K, Uchida Y, Kasumi F (2000) Surgical treatment of hepatic metastases from breast cancer. Breast Cancer Rest Treat 59:177–184

    Article  CAS  Google Scholar 

  10. Elias D, Maisonnette F, Druet-Cabanac M, Ouellet JF, Guinebretiere JM, Spielmann M, Delaloge S (2003) An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 185:158–164

    Article  PubMed  Google Scholar 

  11. Sakamoto Y, Yamamoto J, Yoshimoto M, Kasumi F, Kosuge T, Kokudo N, Makuuchi M (2005) Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients. World J Surg 29:524–527

    Article  PubMed  Google Scholar 

  12. Adam R, Aloia T, Krissat J, Bralet MP, Paule B, Giacchetti S, Delvart V, Azoulay D, Bismuth H, Castaing D (2006) Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 244:897–908

    Article  PubMed  Google Scholar 

  13. Pocard M, Pouillard P, Asselain B, Salmon R (2000) Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur J Surg Oncol 26:155–159

    Article  CAS  PubMed  Google Scholar 

  14. Thelen A, Benckert C, Jonas S, Lopez-Hänninen E, Sehouli J, Neumann U, Rudolph B, Neuhaus P (2008) Liver resection for metastases from breast cancer. J Surg Oncol 97:25–29

    Article  PubMed  Google Scholar 

  15. Lubrano J, Roman H, Tarrab S, Resch B, Marpeau L, Scotté M (2008) Liver resection for breast cancer metastasis: does it improve survival? Surg Today 38:293–299

    Article  PubMed  Google Scholar 

  16. Neri A, Marrelli D, Pedrazzani C, Caruso S, De Stefano A, Mariani F, Megha T, De Marco G, Corso G, Pinto E, Rovello F (2008) Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer. EJSO 34:1299–1303

    CAS  PubMed  Google Scholar 

  17. Konecny GE, Thomssen C, Lück HJ, Unth M, Wang HJ, Kuhn W, Eidtmann H, du Bois A, Olbricht S, Steinfeld D, Mobus V, von Minckwitz G, Dandekar S, Ramos L, Pauletti G, Pegram MD, Janicke F, Slamon DJ (2004) Her-2/neu gene amplification and response to paclitaxel in patients with metastastic breast cancer. J Natl Cancer Inst 96:1141–1151

    Article  CAS  PubMed  Google Scholar 

  18. Gennari L, Doci R, Bozzetti F, Veronesi U (1982) Proposal for a clinical classification of liver metastases. Tumori 68:443–449

    CAS  PubMed  Google Scholar 

  19. Zhou P, Recht A (2004) Young age and outcome for women with early stage invasive breast carcinoma. Cancer 101(6):1264–1274

    Article  PubMed  Google Scholar 

  20. Matthews R, McNeese M, Montague E, Oswald MJ (1988) Prognostic implications of age in breast cancer patients treated with tumorectomy and irradiation or mastectomy. Int J Radiat Oncol Biol Phys 14:659–663

    Article  CAS  PubMed  Google Scholar 

  21. Eichbaum MH, Kaltwasser M, Bruckner T, de Rossi TM, Schneeweiss A, Sohn C (2006) Prognostic factors for patients with liver metastases from breast cancer. Breast Cancer Res Treat 96:53–62

    Article  PubMed  Google Scholar 

  22. Martinez SR, Young SE, Giuliano AE, Bilchik AJ (2006) The utility of estrogen receptor, progesterone receptor and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases. Am J Surg 191:281–283

    Article  CAS  PubMed  Google Scholar 

  23. Lang JE, Mosalpuria K, Cristofanilli M, Krishnamurthy S, Reuben J, Singh B, Bedrosian I, Meric-Bernstam F, Lucci A (2009) HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer. Breast Cancer Res Treat 113(3):501–507

    Article  CAS  PubMed  Google Scholar 

  24. Ross DT, Kim CY, Tang G, Bohn OL, Beck RA, Ring BZ, Seitz RS, Paik S, Costantino JP, Wolmark N (2008) Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials. Clin Cancer Res 14:6602–6609

    Article  CAS  PubMed  Google Scholar 

  25. Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P (2005) Correlation of Her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma. Breast J 11:278–280

    Article  CAS  PubMed  Google Scholar 

  26. Brown M, Tsodikov A, Bauer K, Parise CA, Caggiano V (2008) The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer. Cancer 112(4):737–747

    Article  PubMed  Google Scholar 

  27. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, Kunstlinger F, Levi F, Bismuth F (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastases. Ann Surg Oncol 8:347–353

    Article  CAS  PubMed  Google Scholar 

  28. de Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R (2008) R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 248(4):626–637

    PubMed  Google Scholar 

  29. Yang SH, Yang KH, Li YP, Zhang YC, He XD, Song AL, Tian JH, Jiang L, Bai ZG, He LF, Liu YL, Ma B (2008) Breast conservation therapy for stage I or stage II breast cancer: a meta-analysis of randomized controlled trials. Ann Oncol 19(6):1039–1044

    Article  CAS  PubMed  Google Scholar 

  30. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN, Terstappen LW (2005) Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23:1420–1430

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Rosalind Roberts for her assistance with the manuscript.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of General Surgery I, IRCCS Istituto Clinico Humanitas, Rozzano, Milan, Italy

    Arianna Rubino, Roberto Doci, Jean Claude Foteuh, Islam Abumalouh & Leandro Gennari

  2. Biostatistic Unit, IRCCS Istituto Clinico Humanitas, Rozzano, Milan, Italy

    Emanuela Morenghi

  3. Department of General Surgery I, A. Manzoni Hospital, Lecco, Italy

    Susanna Fissi & Casimiro Giorgetta

  4. Department of Anatomic Pathology, IRCCS Istituto Clinico Humanitas, Rozzano, Milan, Italy

    Luca Di Tommaso

  5. Department of Senology, Istituto Clinico Humanitas, 20089, Rozzano, Milan, Italy

    Arianna Rubino

Authors
  1. Arianna Rubino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roberto Doci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean Claude Foteuh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emanuela Morenghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Susanna Fissi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Casimiro Giorgetta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Islam Abumalouh
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Luca Di Tommaso
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Leandro Gennari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arianna Rubino.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rubino, A., Doci, R., Foteuh, J.C. et al. Hepatic metastases from breast cancer. Updates Surg 62, 143–148 (2010). https://doi.org/10.1007/s13304-010-0026-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13304-010-0026-7

Keywords

Search

Navigation